From the Field to the Ring: Why One Athlete Turned to Stem Cell Therapy
Written by Dr. David Greene, MD, PhD, MBA on April 13, 2026
For most people, physical wear accumulates slowly across decades. For professional athletes who compete across multiple elite sports, that timeline compresses dramatically. Careers in high-contact athletics, college football, the NFL, the Arena Football League, and professional wrestling don’t just test the body. They systematically stress joints, connective tissue, and the spine in ways that conventional medicine often struggles to fully address.
That’s the reality one multi-sport professional athlete confronted when evaluating his options for chronic pain. After competing at every level from high school sports through the University of Florida football program, the NFL, the Arena Football League, and ultimately the WWE, he arrived at a point familiar to many former elite athletes: his body had absorbed years of punishment, and the standard approaches to pain management were no longer delivering the results he needed.
His conclusion was direct: “I don’t want any more temporary relief. I want lifelong relief.”
That search for a durable solution led him to R3 Stem Cell.
Professional athletes are frequently studied in sports medicine research because their injury patterns are both well-documented and extreme. What distinguishes multi-sport athletes — those who transition from collegiate football to professional leagues to contact entertainment like professional wrestling- is the sheer accumulation of acute and repetitive stress injuries over time.
Common conditions in this population include:
Osteoarthritis of the knees, hips, and shoulders from repetitive impact
Chronic tendinopathy in load-bearing tendons
Intervertebral disc degeneration from compressive and rotational spinal forces
Ligament laxity or scarring from repeated sprains and surgical repairs
Standard treatment options for chronic musculoskeletal pain — anti-inflammatory medications, corticosteroid injections, physical therapy, and surgery — are effective for many patients. However, they each carry meaningful limitations in the context of long-term, multi-site athletic injury:
Treatment | Limitation |
NSAIDs / pain medications | Symptom management only; potential GI and cardiovascular risks with long-term use |
Corticosteroid injections | Temporary relief; repeated use may accelerate cartilage breakdown |
Physical therapy | Beneficial for function, but it does not regenerate damaged tissue |
Surgery | Appropriate for structural repair, but recovery is prolonged and outcomes vary |
The athlete’s framing — rejecting “temporary relief” in favor of something lasting — reflects a clinically significant gap that regenerative medicine is actively trying to address.
Stem cell therapy is a form of regenerative medicine that uses biologically active cells — most commonly mesenchymal stem cells (MSCs) derived from bone marrow or adipose (fat) tissue — to support the body’s natural repair processes. Rather than masking pain, the theoretical goal is to encourage the regeneration or healing of damaged tissue at the cellular level.
In orthopedic and sports medicine contexts, stem cell therapies are being investigated for:
Patients need to understand that while stem cell therapy is generating significant scientific interest, the evidence base is still maturing. Here is an honest summary of the current landscape:
Where evidence is more encouraging: Systematic reviews, including several published in Stem Cells Translational Medicine, have found that MSC-based treatments for knee osteoarthritis show statistically significant improvements in pain and function scores compared to baseline, with a generally favorable safety profile. A 2021 review in the Orthopaedic Journal of Sports Medicine noted meaningful patient-reported outcome improvements in multiple trials, though larger randomized controlled trials are still needed.
Where evidence is mixed or still emerging: For conditions like disc degeneration and rotator cuff repair, early-phase clinical trials show promise, but head-to-head comparisons with surgical standards of care remain limited. The FDA continues to regulate stem cell products carefully, and patients should ensure that any provider they work with operates within a compliant framework.
What patients should ask:
What type of cells are being used and from what source?
Is this an FDA-compliant procedure?
What outcomes data does this clinic have for my specific condition?
What does the treatment protocol involve, including the number of sessions and follow-up?
One of the more telling aspects of this athlete’s decision-making was how he evaluated providers. Having spent a career in environments where performance outcomes are measurable and accountability is high, he approached medical decisions the same way: “Anything involving my body, I want to go to a place that I know has a proven track record of success.”
This reflects a broader shift in how patients — particularly high-functioning individuals with significant physical stakes — are selecting regenerative medicine providers. The criteria that matter most tend to be:
Clinical experience with the specific conditions being treated
Transparent outcomes data and patient testimonials from comparable cases
Provider credentials in regenerative or sports medicine
Compliance and safety protocols , including proper cell sourcing and handling
R3 Stem Cell has built its practice around serving patients across this spectrum, from everyday individuals managing joint pain to professional athletes with complex, multi-site injury histories. Their clinical team works to match patients with appropriate regenerative protocols based on the severity of their condition and treatment goals.
Patients who tend to be evaluated as good candidates for regenerative medicine approaches generally share some common characteristics:
Patients with active infection or certain autoimmune conditions
Those requiring urgent structural repair (e.g., complete ligament rupture)
Patients whose conditions are better addressed by established surgical standards of care
A thorough evaluation by a qualified regenerative medicine provider is essential before determining whether stem cell therapy is appropriate for any individual patient.
What makes this athlete’s story clinically relevant, beyond the profile, is the question he is really asking. It is the same question a growing number of patients are bringing to regenerative medicine consultations: Is there an approach that addresses the underlying problem, not just the pain signal?
Stem cell therapy does not guarantee permanent resolution, and reputable providers will be the first to communicate that clearly. But for patients who have exhausted or are wary of conventional options, it represents a scientifically grounded pathway worth serious evaluation.
R3 Stem Cell offers free consultations to help patients understand whether regenerative treatment is appropriate for their specific situation, and what realistic outcomes might look like based on their condition and history.
Most patients begin noticing improvement between four and twelve weeks post-treatment, though this varies significantly depending on the condition, severity, and the patient’s overall health. Some patients report continued improvement for up to six to twelve months.
In the United States, most stem cell therapy procedures for orthopedic conditions are currently considered investigational and are not covered by standard health insurance plans. Patients should discuss financing options with their provider.
Platelet-rich plasma (PRP) uses growth factors concentrated from the patient’s own blood to support healing. Stem cell therapy introduces regenerative cells, either from the patient or a donor source, that may have a broader capacity to support tissue repair. Both are used in regenerative medicine and are sometimes combined.
Look for providers who are transparent about the source and type of cells used, operate within FDA regulatory guidelines, have licensed physicians overseeing care, and can provide patient outcome data or peer-reviewed references to support their protocols.
Contact Us